Qube Research & Technologies (QRT)’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 2917 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 2886 |
|
|
2024
Q4 | – | Sell |
-107,377
| Closed | -$4.39M | – | 2871 |
|
|
2024
Q3 | $4.39M | Sell |
107,377
-162,717
| -60% | -$6.65M | 0.01% | 1150 |
|
|
2024
Q2 | $10.4M | Buy |
+270,094
| New | +$10.4M | 0.02% | 723 |
|
|
2024
Q1 | – | Sell |
-432,648
| Closed | -$16M | – | 4079 |
|
|
2023
Q4 | $16M | Buy |
+432,648
| New | +$16M | 0.03% | 477 |
|
|
2023
Q2 | – | Sell |
-117,622
| Closed | -$4.18M | – | 2541 |
|
|
2023
Q1 | $4.18M | Buy |
117,622
+96,877
| +467% | +$3.45M | 0.02% | 664 |
|
|
2022
Q4 | $729K | Sell |
20,745
-750,678
| -97% | -$26.4M | ﹤0.01% | 1278 |
|
|
2022
Q3 | $22.7M | Buy |
+771,423
| New | +$22.7M | 0.14% | 198 |
|
|
2022
Q2 | – | Sell |
-298,593
| Closed | -$16.3M | – | 2733 |
|
|
2022
Q1 | $16.3M | Buy |
298,593
+246,835
| +477% | +$13.4M | 0.14% | 184 |
|
|
2021
Q4 | $2.85M | Sell |
51,758
-53,337
| -51% | -$2.94M | 0.02% | 709 |
|
|
2021
Q3 | $5.02M | Buy |
+105,095
| New | +$5.02M | 0.06% | 408 |
|
|
2021
Q2 | – | Sell |
-76,972
| Closed | -$3.43M | – | 2457 |
|
|
2021
Q1 | $3.43M | Buy |
76,972
+26,019
| +51% | +$1.16M | 0.05% | 454 |
|
|
2020
Q4 | $2.34M | Sell |
50,953
-53,768
| -51% | -$2.47M | 0.03% | 551 |
|
|
2020
Q3 | $4.93M | Buy |
104,721
+41,041
| +64% | +$1.93M | 0.07% | 358 |
|
|
2020
Q2 | $3.25M | Buy |
+63,680
| New | +$3.25M | 0.05% | 495 |
|
|
2020
Q1 | – | Sell |
-16,650
| Closed | -$978K | – | 1346 |
|
|
2019
Q4 | $978K | Buy |
+16,650
| New | +$978K | 0.03% | 624 |
|
|
2018
Q2 | – | Sell |
-21,678
| Closed | -$1.06M | – | 864 |
|
|
2018
Q1 | $1.06M | Buy |
+21,678
| New | +$1.06M | 0.41% | 37 |
|